CCL2 and breast neoplasm: Triple-negative subtype of breast tumors expressed higher levels of MCP1 and CD14 than those of luminal subtype breast tumors and bone metastatic status exhibited higher MCP1 and CD14 levels compared to brain metastatic status (Figure S1).